Candida auris, multidrug-resistant (MDR) yeast, has been causing invasive healthcare associated infections with high mortality in nine countries on four continents since 2009. The CDC, concerned with its potential to emerge in the United States, is alerting U.S. healthcare facilities to be on the lookout for C. auris in patients, particularly those most susceptible to yeast infections. The precise mode of transmission within the healthcare facility is not known; however, experience during these outbreaks suggests that C. auris might contaminate the environment of rooms of colonized or infected patients. Evidenced-based infection control practices and environmental cleaning may help prevent transmission.
According to the CDC, here’s what hospitals need to do...
- Reporting —Healthcare facilities who suspect they have a patient with auris infection should contact state/local public health authorities and CDC (email@example.com).
- Laboratory Diagnosis —Diagnostic devices based on matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) can differentiate auris, but not all devices currently include C. auris in the reference database to allow for detection. Molecular methods based on sequencing the D1-D2 region of the 28s rDNA can also identify C. auris. CDC requests that laboratories identifying C. auris isolates in the United States notify their state or local health departments and CDC (firstname.lastname@example.org).
- Infection Control —Patients with C. auris colonization or infection should be placed in single rooms; healthcare personnel should use Standard and Contact Precautions. In addition, state or local health authorities and CDC should be consulted about the need for additional interventions to prevent transmission. CDC is currently working with domestic and international partners to develop definitive infection control guidance.
- Environmental Cleaning -- Anecdotal reports have suggested that auris may persist in the environment. Healthcare facilities housing patients with C. auris infection or colonization should ensure thorough daily and terminal cleaning and disinfection of these patient’s rooms using an EPA-registered hospital grade disinfectant with a fungal claim.
To read the unabridged CDC alert, click here: http://www.cdc.gov/fungal/diseases/candidiasis/candida-auris-alert.html
Content source: Centers for Disease Control and Prevention